The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial.
In the randomized, placebo-controlled, physician-blinded Canadian cooperative trial of cyclophosphamide and plasma exchange, neither active treatment regimens (group I: i.v. cyclophosphamide and prednisone; group II: weekly plasma exchange, oral cyclophosphamide, and prednisone) were superior to pla...
Prif Awduron: | Noseworthy, J, Ebers, G, Vandervoort, M, Farquhar, R, Yetisir, E, Roberts, R |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
1994
|
Eitemau Tebyg
-
The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. 1994 [classical article]
gan: Noseworthy, J, et al.
Cyhoeddwyd: (2001) -
The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial
gan: Nosworthy, J, et al.
Cyhoeddwyd: (2001) -
ACCEPTANCE OF PLACEBO-CONTROL TRIAL DESIGN BY PROGRESSIVE MULTIPLE-SCLEROSIS PATIENTS
gan: Noseworthy, J, et al.
Cyhoeddwyd: (1989) -
Acceptance of placebo-control trial design by progressive multiple sclerosis patients. The Canadian Cooperative Multiple Sclerosis Study Group.
gan: Noseworthy, J, et al.
Cyhoeddwyd: (1989) -
A referendum on clinical trial research in multiple sclerosis: the opinion of the participants at the Jekyll Island workshop.
gan: Noseworthy, J, et al.
Cyhoeddwyd: (1989)